Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(85.7%)
Phase 4
1(14.3%)
7Total
N/A(6)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT07275138Not ApplicableNot Yet Recruiting

Acute Cardiovascular and Neuromuscular Responses to Walking With Blood Flow Restriction (BFR) in Older Adults

Role: collaborator

NCT05512793Not ApplicableCompleted

Clinical Validation of PolyDeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System. Polydeep Advance 2.

Role: collaborator

NCT05513261Not ApplicableCompleted

Clinical Validation of PolyDeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System. Polydeep Advance 3

Role: collaborator

NCT05514301Not ApplicableCompleted

Clinical Validation of Polydeep: an Artificial Intelligence-based Computer-aided Polyp Detection (CADe) and Characterization (CADx) System

Role: collaborator

NCT03110991Not ApplicableCompleted

Cognitive-behavioral Intervention Via a Smartphone App for Depressive Symptoms in Caregivers

Role: collaborator

NCT02292394Not ApplicableCompleted

Brief Telephone Psychological Intervention for Depressive Symptoms in Caregivers

Role: collaborator

NCT00295542Phase 4Completed

Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy

Role: collaborator

All 7 trials loaded